Lenvatinib
CAS 417716-92-8
In Stock
Lenvatinib
Cat. No. STUB-API-LENVATINIBCAS 417716-92-8In Stock
Technical Data
Cat. No.STUB-API-LENVATINIB
CAS417716-92-8
Mol. FormulaC21H19ClN4O4
Mol. Weight426.86 g/mol
IUPAC4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide
SMILESCOC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl
InChIInChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)
InChI KeyWOSKHXYHFSIKNG-UHFFFAOYSA-N
Purity—
Description
Overview
Lenvatinib is used to treat thyroid cancer, kidney cancer, liver cancer, and advanced endometrial cancer
Anant Labs manufacture and furnish high quality Lenvatinib impurities for global markets. Our Lenvatinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Lenvatinib417716-92-8E7080E-7080E 7080ER-203492-00Kisplyx4-{3-Chloro-4-[(Cyclopropylcarbamoyl)amino]phenoxy}-7-Methoxyquinoline-6-Carboxamide4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamideEE083865G2
